Prostate Cancer News on BioPortfolio

J&J shares fall after court refuses to block Zytiga generics

Johnson & Johnsons share price took a beating this week after the US appeals court declined its bid to stop sales of cheap generic versions of its blockbuster prostate cancer drug Zytiga.The company's shares fell around 3 because of the cou...

Treating metastatic prostate cancer in geriatric patients

Dr Shabbir Alibhai speaks to ecancer at the International Society of Geriatric Oncology 2018 conference in Amsterdam about the treatment of metastatic prostate cancer in geriatric patients.He discusses the potential makers that can be. used and also...

Pages